Longevity
Scientists find the protein that slows egg aging in mice
By Life and Health Today Staff, . Life and Health Today.
Eggs age differently from almost every other cell in the body, and the consequences are well documented: the older a woman is, the higher the risk that her eggs carry the wrong number of chromosomes. What has been far less clear is why some eggs hold up better than others, and whether any internal mechanism slows the damage. A study published in Nature Aging now identifies a protein, OMC1, that appears to do exactly that, at least in mice.
What happens inside an aging egg
To understand the finding, a little cell biology helps. When a female mammal is still a fetus, her eggs begin a process called meiosis, the specialized cell division that eventually produces eggs with half the normal chromosome count, ready to be fertilized. Then meiosis pauses, sometimes for decades in humans, and the eggs wait.
During that long pause, structures called cohesins hold the chromosomes together like molecular staples. The key cohesin protein in eggs is called REC8, and according to the Nature Aging paper, it is not replaced once it is laid down in fetal life. It simply has to last. Over time, REC8 cohesin degrades, and when meiosis finally resumes in adulthood, chromosomes that were once held neatly together can separate incorrectly, a state called aneuploidy, meaning the egg ends up with too many or too few chromosomes. Aneuploidy is a leading cause of failed pregnancies and conditions including Down syndrome.
What OMC1 does
Researchers identified OMC1 as a protein found specifically in oocytes, the cells that become eggs. Using mice in which the gene for OMC1 had been knocked out, the team showed that the protein sits alongside REC8 cohesin on the chromosome structures from fetal development all the way through to the completion of meiosis in adult life. Without OMC1, cohesin maintenance failed and age-associated chromosome segregation errors increased.
The Nature Aging paper describes OMC1 as "an oocyte-specific chromosomal protein required for the maintenance of chromosome cohesion through reproductive life," a factor that, until now, was unknown. The authors write that the findings offer insight into "the female germ-cell-intrinsic molecular basis that supports reproductive longevity by suppressing age-associated chromosome cohesion loss."
What this does not yet show
All of the experimental work was done in mice. Whether OMC1 plays the same role in human eggs, whether its activity varies between women, and whether it could ever be targeted therapeutically are questions the study does not answer. The paper establishes that the protein exists, that it is required for cohesin maintenance in the mouse model, and that losing it accelerates the kind of chromosome errors associated with age. That is a meaningful step in understanding egg aging, not a treatment.
No human trials are described in the report. For anyone thinking about fertility or reproductive timing, the finding does not change what is currently available, and those questions belong with a reproductive specialist who knows an individual's history.
What the study does offer is a clearer picture of why egg quality declines with age at the molecular level, and a specific protein that future research can investigate. If OMC1 function in human eggs turns out to mirror what was found in mice, it would identify a target that researchers did not previously know to look for.
Life & Health Today provides information for educational purposes only, not medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional.